Financial results - NUTRA PHARMA CONSULTING S.R.L.

Financial Summary - Nutra Pharma Consulting S.r.l.
Unique identification code: 41299733
Registration number: J2019008226408
Nace: 6310
Sales - Ron
29.150
Net Profit - Ron
9.633
Employees
1
Open Account
Company Nutra Pharma Consulting S.r.l. with Fiscal Code 41299733 recorded a turnover of 2024 of 29.150, with a net profit of 9.633 and having an average number of employees of 1. The company operates in the field of Prelucrarea datelor, administrarea paginilor web şi activităţi conexe having the NACE code 6310.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Nutra Pharma Consulting S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 13.848 31.292 46.838 56.444 40.339 29.150
Total Income - EUR - - - - 13.848 31.292 46.838 56.444 40.339 29.150
Total Expenses - EUR - - - - 3.603 12.940 11.061 15.066 18.116 17.682
Gross Profit/Loss - EUR - - - - 10.245 18.352 35.777 41.379 22.224 11.468
Net Profit/Loss - EUR - - - - 10.106 18.039 35.318 40.882 21.869 9.633
Employees - - - - 0 1 1 2 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -27.3%, from 40.339 euro in the year 2023, to 29.150 euro in 2024. The Net Profit decreased by -12.114 euro, from 21.869 euro in 2023, to 9.633 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Nutra Pharma Consulting S.r.l.

Rating financiar

Financial Rating -
NUTRA PHARMA CONSULTING S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Nutra Pharma Consulting S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nutra Pharma Consulting S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Nutra Pharma Consulting S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nutra Pharma Consulting S.r.l. - CUI 41299733

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 0 0 0
Current Assets - - - - 10.914 31.097 70.349 48.178 35.394 44.024
Inventories - - - - 20 20 19 19 19 19
Receivables - - - - 10 7.360 8.751 47.723 25.233 41.174
Cash - - - - 10.884 23.718 61.579 436 10.142 2.831
Shareholders Funds - - - - 10.149 27.995 62.693 40.923 25.976 34.862
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 765 3.102 7.656 7.255 9.417 9.162
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6310 - 6310"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 44.024 euro in 2024 which includes Inventories of 19 euro, Receivables of 41.174 euro and cash availability of 2.831 euro.
The company's Equity was valued at 34.862 euro, while total Liabilities amounted to 9.162 euro. Equity increased by 9.031 euro, from 25.976 euro in 2023, to 34.862 in 2024.

Risk Reports Prices

Reviews - Nutra Pharma Consulting S.r.l.

Comments - Nutra Pharma Consulting S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.